.Merck trumps profits requirements, increases sales overview on strong requirement for top medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Estimates as Keytruda Sales Growth BloombergMerck Sell: Pharma Giant Posts Tough End Results, Yet Expectation Falls Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income as well as purchases expectations surrounded by Keytruda strong point, yet offers combined full-year expectation MarketWatch.